| Code | CSB-RA004847MA3HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| FC | 1:50-1:200 |
CCR8, or C-C chemokine receptor type 8, serves as a critical G protein-coupled receptor that mediates chemotactic responses in immune cells, particularly regulatory T cells within the tumor microenvironment. This receptor has emerged as a compelling target in immuno-oncology research, as CCR8-expressing Tregs are frequently enriched in solid tumors and associated with immunosuppressive conditions that limit anti-tumor immunity. Understanding CCR8 biology and developing strategies to modulate its function represents an active frontier in cancer immunotherapy research.
This recombinant monoclonal antibody, clone 6B12, offers researchers the consistency and reliability essential for longitudinal studies and reproducible results. Generated against recombinant human CCR8 protein and produced with a human IgG1 framework, this antibody provides sequence-defined specificity that eliminates the lot-to-lot variability inherent in traditional hybridoma-derived reagents. Affinity chromatography purification ensures high purity suitable for demanding applications.
Validation studies demonstrate robust performance in flow cytometry and ELISA applications. Flow cytometric analysis clearly distinguishes between untransfected CHO-K1 cells and human CCR8-transfected CHO-K1 stable cells, confirming specific surface detection of the receptor. Functional ELISA testing reveals strong binding activity, with EC50 values ranging from 11.20 to 15.63 ng/mL when detecting immobilized human CCR8 protein, indicating high-affinity target recognition. Recommended dilutions for flow cytometry range from 1:20 to 1:200, providing flexibility for optimization across experimental conditions.
This antibody supports immunology research programs investigating Treg biology, chemokine signaling networks, and therapeutic targeting strategies in oncology and inflammatory disease contexts.
There are currently no reviews for this product.